Registro:

Referencias:

• Miller, K.D., Siegel, R.L., Lin, C.C., Cancer treatment and survivorship statistics, 2016 (2016) CA Cancer J. Clin., 66, pp. 271-289
• Saloustros, E., Georgoulias, V., Docetaxel in the treatment of advanced non-small-cell lung cancer (2008) Expert Rev. Anticancer Ther., 8, pp. 1207-1222
• Saloustros, E., Mavroudis, D., Georgoulias, V., Paclitaxel and docetaxel in the treatment of breast cancer (2008) Expert Opin. Pharmacother., 9, pp. 2603-2616
• Montero, A., Fossella, F., Hortobagyi, G., Valero, V., Docetaxel for treatment of solid tumours: a systematic review of clinical data (2005) Lancet Oncol., 6, pp. 229-239
• Berchem, G.J., Bosseler, M., Mine, N., Avalosse, B., Nanomolar range docetaxel treatment sensitizes MCF-7 cells to chemotherapy induced apoptosis, induces G2M arrest and phosphorylates bcl-2 (1999) Anticancer Res., 19, pp. 535-540
• Hernández-Vargas, H., Palacios, J., Moreno-Bueno, G., Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis (2007) Oncogene, 26, pp. 2902-2913
• Huang, W., Zhang, J., Dorn, H.C., Zhang, C., Assembly of bio-nanoparticles for double controlled drug release (2013) PLoS One, 8
• Kuppens, I., Current state of the art of new tubulin inhibitors in the clinic (2006) Curr. Clin. Pharmacol., 1, pp. 57-70
• Engels, F.K., Mathot, R.A.A., Verweij, J., Alternative drug formulations of docetaxel: a review (2007) Anticancer Drugs, 18, pp. 95-103
• Katsumata, N., Docetaxel: an alternative taxane in ovarian cancer (2003) Br. J. Cancer, 89, pp. S9-S15
• Baker, J., Ajani, J., Scotté, F., Docetaxel-related side effects and their management (2009) Eur. J. Oncol. Nurs., 13, pp. 49-59
• Agrawal, R., Shanavas, A., Yadav, S., Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel (2012) J. Biomed. Nanotechnol., 8, pp. 19-28
• Saremi, S., Dinarvand, R., Kebriaeezadeh, A., Enhanced oral delivery of docetaxel using thiolated chitosan nanoparticles: preparation, in vitro and in vivo studies (2013) Biomed Res. Int., 2013
• Rafiei, P., Haddadi, A., Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile (2017) Int. J. Nanomed., 12, pp. 935-947
• Schwarz, C., Mehnert, W., Lucks, J.S., Müller, R.H., Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization (1994) J. Control. Release, 30, pp. 83-96
• Umeyor, E.C., Kenechukwu, F.C., Ogbonna, J.D., Preparation of novel solid lipid microparticles loaded with gentamicin and its evaluation in vitro and in vivo (2012) J. Microencapsul., 29, pp. 296-307
• Yuan, Q., Han, J., Cong, W., Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity (2014) Int. J. Nanomed., 9, pp. 4829-4846
• Zheng, D., Li, D., Lu, X., Feng, Z., Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery (2010) Oncol. Rep., 23, pp. 717-724
• Cacicedo, M.L., Islan, G.A., León, I.E., Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment (2018) Colloids Surf. B Biointerfaces, 170, pp. 596-608
• Azzi, S., Hebda, J.K., Gavard, J., Vascular permeability and drug delivery in cancers (2013) Front. Oncol., 3, p. 211
• Steichen, S.D., Caldorera-Moore, M., Peppas, N.A., A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics (2013) Eur. J. Pharm. Sci., 48, pp. 416-427
• Maeda, H., Nakamura, H., Fang, J., The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo (2013) Adv. Drug Deliv. Rev., 65, pp. 71-79
• Kobayashi, H., Watanabe, R., Choyke, P.L., Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? (2014) Theranostics, 4, pp. 81-89
• Weyhers, H., Ehlers, S., Hahn, H., Solid lipid nanoparticles (SLN)–effects of lipid composition on in vitro degradation and in vivo toxicity (2006) Pharmazie, 61, pp. 539-544
• Pitto-Barry, A., Barry, N.P.E., Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances (2014) Polym. Chem., 5, pp. 3291-3297
• Wood, I., Martini, M.F., Albano, J.M.R., Coarse grained study of pluronic F127: comparison with shorter co-polymers in its interaction with lipid bilayers and self-aggregation in water (2016) J. Mol. Struct., 1109, pp. 106-113
• Kabanov, A.V., Batrakova, E.V., Alakhov, V.Y., Pluronic® block copolymers for overcoming drug resistance in cancer (2002) Adv. Drug Deliv. Rev., 54, pp. 759-779
• Sharma, A.K., Zhang, L., Li, S., Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant (2008) J. Control. Release, 131, pp. 220-227
• Venne, A., Li, S., Mandeville, R., Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug- resistant cells (1996) Cancer Res., 56, pp. 3626-3629
• Lage, H., ABC-transporters: implications on drug resistance from microorganisms to human cancers (2003) Int. J. Antimicrob. Agents, 22, pp. 188-199
• Chen, Z., Shi, T., Zhang, L., Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade (2016) Cancer Lett., 370, pp. 153-164
• Batrakova, E.V., Li, S., Vinogradov, S.V., Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization (2001) J. Pharmacol. Exp. Ther., 299, pp. 483-493
• Song, C.K., Balakrishnan, P., Shim, C.-K., Enhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cells (2011) J. Microencapsul., 28, pp. 575-581
• Wei, Z., Yuan, S., Hao, J., Fang, X., Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity (2013) Eur. J. Pharm. Biopharm., 83, pp. 266-274
• Alakhova, D.Y., Kabanov, A.V., Pluronics and MDR reversal: an update (2014) Mol. Pharm., 11, pp. 2566-2578
• Jain, D., Athawale, R., Bajaj, A., Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles (2013) Colloids Surf. B Biointerfaces, 109, pp. 59-67
• Mayol, L., Serri, C., Menale, C., Curcumin loaded PLGA–poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells (2015) Eur. J. Pharm. Biopharm., 93, pp. 37-45
• Li, S.-D., Huang, L., Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting (2010) J. Control. Release, 145, pp. 178-181
• Gref, R., Lück, M., Quellec, P., ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption (2000) Colloids Surf. B Biointerfaces, 18, pp. 301-313
• Loureiro, A., Noro, J., Abreu, A.S., Absence of albumin improves in vitro cellular uptake and disruption of poloxamer 407-Based nanoparticles inside Cancer cells (2018) Mol. Pharm., 15, pp. 527-535
• Moraes, C.M., Paula, E., de, Rosa, A.H., Fraceto, L.F., Validação de metodologia analítica por cromatografia líquida de alta eficiência para quantificação de bupivacaína (S75-R25) em nanoesferas de poli(lactí deo-co-glicolí deo) (2008) Quim. Nova, 31, pp. 2152-2155
• Rodrigues da Silva, G.H., Ribeiro, L.N.M., Mitsutake, H., Optimised NLC: a nanotechnological approach to improve the anaesthetic effect of bupivacaine (2017) Int. J. Pharm., 529, pp. 253-263
• Nahak, P., Karmakar, G., Roy, B., Physicochemical studies on local anaesthetic loaded second generation nanolipid carriers (2015) RSC Adv., 5, pp. 26061-26070
• Chen, H., Wang, Y., Zhai, Y., Development of a ropivacaine-loaded nanostructured lipid carrier formulation for transdermal delivery (2015) Colloids Surf. A Physicochem. Eng. Asp., 465, pp. 130-136
• Marrink, S.J., Risselada, H.J., Yefimov, S., The MARTINI force field: coarse grained model for biomolecular simulations (2007) J. Phys. Chem. B, 111, pp. 7812-7824
• Yesylevskyy, S.O., Schäfer, L.V., Sengupta, D., Marrink, S.J., Polarizable water model for the coarse-grained MARTINI force field (2010) PLoS Comput. Biol., 6, pp. 1-17
• Namgung, R., Mi Lee, Y., Kim, J., Poly-cyclodextrin and poly-paclitaxel nano-assembly for anticancer therapy (2014) Nat. Commun., 5
• Berendsen, H.J.C., Postma, J.P.M., van Gunsteren, W.F., Molecular dynamics with coupling to an external bath (1984) J. Chem. Phys., 81, pp. 3684-3690
• Berendsen, H.J.C., van der Spoel, D., van Drunen, R., GROMACS: a message passing parallel molecular dynamics implementation (1995) Comp. Phys. Comm., 91, pp. 43-56
• Müller, R.H., Mäder, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art (2000) Eur. J. Pharm. Biopharm., 50, pp. 161-177
• Ribeiro, L.N.M., Franz-Montan, M., Breitkreitz, M.C., Nanostructured lipid carriers as robust systems for topical lidocaine-prilocaine release in dentistry (2016) Eur. J. Pharm. Sci., 93, pp. 192-202
• Ribeiro, L.N.M., Breitkreitz, M.C., Guilherme, V.A., Natural lipids-based NLC containing lidocaine: from pre-formulation to in vivo studies (2017) Eur. J. Pharm. Sci., 106, pp. 102-112
• Rodenak-Kladniew, B., Islan, G.A., de Bravo, M.G., Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy (2017) Colloids Surf. B Biointerfaces, 154, pp. 123-132
• Yan, F., Zhang, C., Zheng, Y., The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity (2010) Nanomed. Nanotechnol. Biol. Med., 6, pp. 170-178
• Jin, M., Piao, S., Jin, T., Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles (2014) J. Huazhong Univ. Sci. Technol. Med. Sci., 34, pp. 66-75
• Jensen, O.A., Prause, J.U., Laursen, H., Shrinkage in preparatory steps for SEM. A study on rabbit corneal endothelium (1981) Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 215, pp. 233-242
• Feng, L., Mumper, R.J., A critical review of lipid-based nanoparticles for taxane delivery (2013) Cancer Lett., 334, pp. 157-175
• Balkwill, F.R., Capasso, M., Hagemann, T., The tumor microenvironment at a glance (2012) J. Cell. Sci., 125, pp. 5591-5596
• Martins, S., Costa-Lima, S., Carneiro, T., Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway (2012) Int. J. Pharm., 430, pp. 216-227
• Kolašinac, N., Kachrimanis, K., Homšek, I., Solubility enhancement of desloratadine by solid dispersion in poloxamers (2012) Int. J. Pharm., 436, pp. 161-170
• Singh, H., Sharma, R., Joshi, M., Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers (2015) Artif. Cells Nanomed. Biotechnol., 43, pp. 263-269
• Zeng, X., Tao, W., Mei, L., Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer (2013) Biomaterials, 34, pp. 6058-6067
• Zaske, L., Perrin, M.-A., Daiguebonne, C., Guillou, O., Docetaxel (Taxotere® trihydrate) forms: crystal structure determination from XRPD & XRSCD data (2004) Mater. Sci. Forum., pp. 443-444. , 411–0. doi: 10.4028/
• Saupe, A., Gordon, K.C., Rades, T., Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy (2006) Int. J. Pharm., 314, pp. 56-62
• Fan, X., Chen, J., Shen, Q., Docetaxel–nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery (2013) Int. J. Pharm., 458, pp. 296-304
• Albano, J.M.R., de, P.E., Pickholz, M., molecular dynamics simulations to study drug delivery systems (2018) Mol. Dyn. InTech.
• Wood, I., Albano, J.M.R., Filho, P.L.O., A sumatriptan coarse-grained model to explore different environments: interplay with experimental techniques (2018) Eur. Biophys. J.
• Pazdur, R., Kudelka, A.P., Kavanagh, J.J., The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere) (1993) Cancer Treat. Rev., 19, pp. 351-386
• Baek, J.-S., Cho, C.-W., Comparison of solid lipid nanoparticles for encapsulating paclitaxel or docetaxel (2015) J. Pharm. Investig., 45, pp. 625-631

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------